{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T04:02:25Z","timestamp":1747368145440,"version":"3.40.5"},"reference-count":30,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>Developmental stuttering is characterized by early childhood onset with repetition of syllables, prolongations, and blockades as well as secondary behavioural abnormalities. Early therapy is important while there is no approved pharmacological approach. Studies associate developmental stuttering with dopamin surplus in the striatum causing dysfunction of cortical speech areas. Consequently, antidopaminergic agents are being investigated to improve symptoms. The evidence in adults is comprised of few studies of poor quality but might hold promise as a new treatment option, as argued in this review.<\/jats:p>","DOI":"10.61409\/v03240229","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T06:16:37Z","timestamp":1724912197000},"page":"1-7","source":"Crossref","is-referenced-by-count":0,"title":["Developmental stuttering in adults"],"prefix":"10.61409","author":[{"given":"Thomas Bauer","family":"M\u00f8lgaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lone","family":"Baandrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"key":"ref0","unstructured":"Stammeforeningen i Danmark. Stammen et kommunikationsproblem. 2023. https:\/\/stammeforeningen.dk\/om-stammen\/stammen-et-kommunikationsproblem\/"},{"key":"ref1","unstructured":"Kristensen K, Larsen EP, \u00d8gard CG. Stammen. L\u00e6geh\u00e5ndbogen. www.sundhed.dk\/sundhedsfaglig\/laegehaandbogen\/paediatri\/tilstande-og-sygdomme\/udviklingsforstyrrelser\/stammen\/"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Ooki S. Genetic and environmental influences on stuttering and tics in Japanese twin children. Twin Res Hum Genet. 2005;8(1):69-75. https:\/\/doi.org\/10.1375\/1832427053435409","DOI":"10.1375\/1832427053435409"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Fagnani C, Fibiger S, Skytthe A, Hjelmborg JVB. Heritability and environmental effects for self-reported periods with stuttering: a twin study from Denmark. Logoped Phoniatr Vocol. 2011;36(3):114-20. https:\/\/doi.org\/10.3109\/14015439.2010.534503","DOI":"10.3109\/14015439.2010.534503"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Rautakoski P, Hannus T, Simberg S et al. Genetic and environmental effects on stuttering: a twin study from Finland. J Fluen Disord. 2012;37(3):202-10. https:\/\/doi.org\/10.1016\/j.jfludis.2011.12.003","DOI":"10.1016\/j.jfludis.2011.12.003"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Wittke-Thompson JK, Ambrose N, Yairi E et al. Genetic studies of stuttering in a founder population. J Fluen Disord. 2007;32:33-50. https:\/\/doi.org\/10.1016\/j.jfludis.2006.12.002","DOI":"10.1016\/j.jfludis.2006.12.002"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Lan J, Song M, Pan C et al. Association between dopaminergic genes (SLC6A3 and DRD2) and stuttering among Han Chinese. J Hum Genet. 2009;54:457-60. https:\/\/doi.org\/10.1038\/jhg.2009.60","DOI":"10.1038\/jhg.2009.60"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Kang C, Riazuddin S, Mundorff J et al. Mutations in the lysosomal enzyme-targeting pathway and persistent stuttering. N Engl J Med. 2010;362(8):677-85. https:\/\/doi.org\/10.1056\/NEJMoa0902630","DOI":"10.1056\/NEJMoa0902630"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Maguire GA, Nguyen DL, Simonson KC, Kurz TL. The pharmacologic treatment of stuttering and its neuropharmacologic basis. Front Neurosci. 2020;14:158. https:\/\/doi.org\/10.3389\/fnins.2020.00158","DOI":"10.3389\/fnins.2020.00158"},{"key":"ref9","unstructured":"Perez HR, Stoeckle JH. Stuttering: clinical and research update. Can Fam Physician Med Fam Can. 2016;6286):479-84"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Maguire GA, Yu BP, Franklin DL, Riley GD. Alleviating stuttering with pharmacological interventions. Expert Opin Pharmacother. 2004;5(7):1565-71. https:\/\/doi.org\/10.1517\/14656566.5.7.1565","DOI":"10.1517\/14656566.5.7.1565"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Wu JC, Maguire G, Riley G et al. A positron emission tomography [18F]deoxyglucose study of developmental stuttering. Neuroreport. 1995;6(3):501-5. https:\/\/doi.org\/10.1097\/00001756-199502000-00024","DOI":"10.1097\/00001756-199502000-00024"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III - the final common pathway. Schizophr Bull. 2009;35(3):549-62. https:\/\/doi.org 10.1093\/schbul\/sbp006","DOI":"10.1093\/schbul\/sbp006"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Johnson KA, Worbe Y, Foote KD et al. Tourette syndrome: clinical features, pathophysiology, and treatment. Lancet Neurol. 2023;22(2):147-58. https:\/\/doi.org\/10.1016\/S1474-4422(22)00303-9","DOI":"10.1016\/S1474-4422(22)00303-9"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Nilles C, Berg L, Fleming C et al. Developmental stuttering, physical concomitants associated with stuttering, and Tourette syndrome: a scoping review. J Fluen Disord. 2023;77:105992. https:\/\/doi.org\/10.1016\/j.jfludis.2023.105992","DOI":"10.1016\/j.jfludis.2023.105992"},{"key":"ref15","unstructured":"Shaygannejad V, Khatoonabadi SA, Shafiei B et al. Olanzapine versus haloperidol: which can control stuttering better? Int J Prev Med. 2013;4(suppl 2):S270-S273"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Maguire G, Franklin D, Vatakis NG et al. Exploratory randomized clinical study of pagoclone in persistent developmental stuttering: the EXamining Pagoclone for peRsistent dEvelopmental Stuttering Study. J Clin Psychopharmacol. 2010;30(1):48-56. https:\/\/doi.org\/10.1097\/JCP.0b013e3181caebbe","DOI":"10.1097\/JCP.0b013e3181caebbe"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Stager SV, Calis K, Grothe D et al. Treatment with medications affecting dopaminergic and serotonergic mechanisms: effects on fluency and anxiety in persons who stutter. J Fluen Disord. 2005;30(4):319-35. https:\/\/doi.org\/10.1016\/j.jfludis.2005.09.004","DOI":"10.1016\/j.jfludis.2005.09.004"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Maguire GA, Riley GD, Franklin DL et al. Olanzapine in the treatment of developmental stuttering: a double-blind, placebo-controlled trial. Ann Clin Psychiatry. 2004;16(2):63-7. https:\/\/doi.org\/10.1080\/10401230490452834","DOI":"10.1080\/10401230490452834"},{"key":"ref19","unstructured":"Charoensook J, Maguire GA. A case series on the effectiveness of lurasidone in patients with stuttering. Ann Clin Psychiatry. 2017;29(3):191-4."},{"key":"ref20","unstructured":"Maguire GA, LaSalle L, Hoffmeyer D et al. Ecopipam as a pharmacologic treatment of stuttering. Ann Clin Psychiatry. 2019;31:164-168"},{"key":"ref21","unstructured":"Riley GD. SSI-4: Stuttering Severity Instrument - fourth edition. 2009"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Riley J, Riley G, Maguire G. Subjective screening of stuttering severity, locus of control and avoidance: research edition. J Fluen Disord. 2004;29(1):51-62. https:\/\/doi.org\/10.1016\/j.jfludis.2003.12.001","DOI":"10.1016\/j.jfludis.2003.12.001"},{"key":"ref23","unstructured":"Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4(7):28-37."},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. https:\/\/doi.org\/10.1136\/bmj.i4919","DOI":"10.1136\/bmj.i4919"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","DOI":"10.1136\/bmj.l4898"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Laiho A, Elovaara H, Kaisamatti K et al. Stuttering interventions for children, adolescents, and adults: a systematic review as a part of clinical guidelines. J Commun Disord. 2022;99:106242. https:\/\/doi.org\/10.1016\/j.jcomdis.2022.106242","DOI":"10.1016\/j.jcomdis.2022.106242"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Carey B, O'Brian S, Onslow M et al. Randomized controlled non-inferiority trial of a telehealth treatment for chronic stuttering: the Camperdown Program. Int J Lang Commun Disord. 2010;45(1):108-20. https:\/\/doi.org\/10.3109\/13682820902763944","DOI":"10.3109\/13682820902763944"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Menzies RG, O'Brian S, Onslow M et al. An experimental clinical trial of a cognitive-behavior therapy package for chronic stuttering. J Speech Lang Hear Res. 2008;51(6):1451-64. https:\/\/doi.org\/10.1044\/1092-4388(2008\/07-0070)","DOI":"10.1044\/1092-4388(2008\/07-0070)"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Lee K, Manning WH, Herder C. Origin and pawn scaling for adults who do and do not stutter: a preliminary comparison. J Fluen Disord. 2015;45:73-81. https:\/\/doi.org\/10.1016\/j.jfludis.2015.05.001","DOI":"10.1016\/j.jfludis.2015.05.001"}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T06:16:19Z","timestamp":1747289779000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V03240229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":30,"URL":"https:\/\/doi.org\/10.61409\/v03240229","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"type":"print","value":"0041-5782"},{"type":"electronic","value":"1603-6824"}],"subject":[],"published":{"date-parts":[[2024,8,26]]}}}